Xcout Intel
Arrakis Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Arrakis Therapeutics, Inc. among biopharmaceuticals companies — ranked by similarity to what Arrakis Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Arrakis Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. is a biopharmaceutical company located in Waltham, Massachusetts. The company focuses on discovering and developing small-molecule medicines that target RNA to address various serious diseases.
Arrakis Therapeutics, Inc. at a glance
Arrakis Therapeutics, Inc. is a biopharmaceuticals company headquartered in United States, founded in 2015. Its most recent funding round raised $15M in April 2019. Xcout tracks 11 named people at Arrakis Therapeutics, Inc., including Mark DeLong (Chief Executive Officer). Xcout recorded 2 job postings from Arrakis Therapeutics, Inc. in the last 90 days.
Arrakis Therapeutics, Inc. leadership
- Mark DeLongChief Executive Officer
- Michael GilmanPresident
- Heather LounsburyChief Operating Officer
- Domi StickensChief Scientific Officer
- James MutambaChief Business Officer
- Eric SchwartzSr. Vice President, Chemistry
5 more named people on record for Arrakis Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Arrakis Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $15M | — | |
| Series B | $75M | 12 named | |
| SEC Form D filing | $13.2M | — | |
| Series A | $38M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Arrakis Therapeutics, Inc.
Xcout recorded 2 job postings from Arrakis Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Arrakis Therapeutics, Inc.'s hiring signals →
Top 12 Arrakis Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Arrakis Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Drug Discovery
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Drug Discovery
Renasis Bio Ltd. is a stealth-mode private company headquartered in Rehovot, Israel, established in 2025. The firm is developing an AI-driven drug discovery platform focused on RNA-targeting small molecules to advance RNA druggability.
Drug Discovery
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Similar biopharmaceuticals company
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Similar biopharmaceuticals company
Actimis Pharmaceuticals, Inc. is a privately held, venture-backed biopharmaceutical company focused on the research and development of small molecule therapeutics for respiratory and inflammatory disorders, such as asthma and rheumatoid arthritis.
Similar biopharmaceuticals company
CinCor Pharma, Inc. is a U.S.-based drug developer focused on heart and kidney treatments, which was acquired by AstraZeneca. The company was headquartered in Waltham, Massachusetts.
Drug Discovery
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Drug Discovery
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Similar biopharmaceuticals company
IDRx, Inc. is a clinical-stage biotechnology company headquartered in Plymouth, Massachusetts (with additional corporate office presence in New York). Founded in 2021, the company focuses on developing precision therapeutics and has entered an acquisition agreement with GSK.
Similar biopharmaceuticals company
Altay Therapeutics, Inc. is a biotechnology company founded in 2019 and headquartered in the San Francisco Bay Area, California. The company focuses on developing therapeutics within the biotechnology sector.
Drug Discovery
Astria Therapeutics, Inc. is a public biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to developing life-changing therapies for patients.
Similar biopharmaceuticals company
Intarcia Therapeutics, Inc. is a biopharmaceutical research company headquartered in Boston, Massachusetts, focused on developing treatments in various therapeutic areas.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Arrakis Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Arrakis Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →